Vimarsana.com
Latest Breaking News On - Bringing innovative meds - Page 1 : vimarsana.com
Eli Lilly to Withdraw Insulin Basaglar from Indian Market; Product No Longer Profitable, Say Experts
American pharma major Eli Lilly has decided to withdraw insulin Glargine, sold under the brand name of Basaglar KwikPen, from the Indian market.
United-states
India
American
Eli-lilly
Basaglar-kwikpen
National-pharmaceuticals-pricing-authority
Cipla
Biocon
Lilly-india
Mankind-pharma
Eris-lifesciences
Bringing-innovative-meds
vimarsana © 2020. All Rights Reserved.